Literature DB >> 17467916

The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.

M Petraschka1, S Li, T L Gilbert, R E Westenbroek, M R Bruchas, S Schreiber, J Lowe, M J Low, J E Pintar, C Chavkin.   

Abstract

Phosphorylation of specific sites in the second intracellular loop and in the C-terminal domain have previously been suggested to cause desensitization and internalization of the mu-opioid receptor (MOP-R). To assess sites of MOP-R phosphorylation in vivo, affinity-purified, phosphoselective antibodies were raised against either phosphothreonine-180 in the second intracellular loop (MOR-P1) or the C-terminal domain of MOP-R containing phosphothreonine-370 and phosphoserine-375 (MOR-P2). We found that MOR-P2-immunoreactivity (IR) was significantly increased within the striatum of wild-type C57BL/6 mice after injection of the agonist fentanyl. Pretreatment with the antagonist naloxone blocked the fentanyl-induced increase. Furthermore, mutant mice lacking MOP-R showed only non-specific nuclear MOR-P2-IR before or after fentanyl treatment, confirming the specificity of the MOR-P2 antibodies. To assess whether MOP-R phosphorylation occurs following endogenous opioid release, we induced chronic neuropathic pain by partial sciatic nerve ligation (pSNL), which caused a significant increase in MOR-P2-IR in the striatum. pSNL also induced signs of mu opioid receptor tolerance demonstrated by a rightward shift in the morphine dose response in the tail withdrawal assay and by a reduction in morphine conditioned place preference (CPP). Mutant mice selectively lacking all forms of the beta-endorphin peptides derived from the proopiomelanocortin (Pomc) gene did not show increased MOR-P2-IR, decreased morphine antinociception, or reduced morphine CPP following pSNL. In contrast gene deletion of either proenkephalin or prodynorphin opioids did not block the effects of pSNL. These results suggest that neuropathic pain caused by pSNL in wild-type mice activates the release of the endogenous opioid beta-endorphin, which subsequently induces MOP-R phosphorylation and opiate tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467916      PMCID: PMC2012364          DOI: 10.1016/j.neuroscience.2007.03.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

1.  Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.

Authors:  R El Kouhen; A L Burd; L J Erickson-Herbrandson; C Y Chang; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

2.  Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.

Authors:  J Zhang; S S Ferguson; L S Barak; S R Bodduluri; S A Laporte; P Y Law; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

3.  Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene.

Authors:  I Kitchen; S J Slowe; H W Matthes; B Kieffer
Journal:  Brain Res       Date:  1997-12-05       Impact factor: 3.252

4.  Agonist-induced mu opioid receptor phosphorylation and functional desensitization in rat thalamus.

Authors:  H B Deng; Y Yu; H Wang; W Guang; J B Wang
Journal:  Brain Res       Date:  2001-04-20       Impact factor: 3.252

5.  Generation of dynorphin knockout mice.

Authors:  N Sharifi; N Diehl; L Yaswen; M B Brennan; U Hochgeschwender
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

6.  Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report.

Authors:  C P Bleeker; R C Bremer; D A Dongelmans; R T van Dongen; B J Crul
Journal:  Eur J Pain       Date:  2001       Impact factor: 3.931

7.  Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions.

Authors:  I Brüggemann; S Schulz; D Wiborny; V Höllt
Journal:  Brain Res Mol Brain Res       Date:  2000-12-28

8.  Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.

Authors:  J P Celver; J Lowe; A Kovoor; V V Gurevich; C Chavkin
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

9.  Mu opioid receptor phosphorylation, desensitization, and ligand efficacy.

Authors:  Y Yu; L Zhang; X Yin; H Sun; G R Uhl; J B Wang
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

10.  Female preproenkephalin-knockout mice display altered emotional responses.

Authors:  A Ragnauth; A Schuller; M Morgan; J Chan; S Ogawa; J Pintar; R J Bodnar; D W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  26 in total

Review 1.  Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Transl Res       Date:  2021-02-07       Impact factor: 7.012

Review 2.  Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function.

Authors:  Lisa R Goldberg; Thomas J Gould
Journal:  Eur J Neurosci       Date:  2018-07-20       Impact factor: 3.386

Review 3.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

Review 4.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

5.  Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.

Authors:  Michelle R Hoot; Laura J Sim-Selley; Dana E Selley; Krista L Scoggins; William L Dewey
Journal:  Brain Res       Date:  2011-06-16       Impact factor: 3.252

6.  The Relationship Between β-Endorphin and Experimental Pain Sensitivity in Older Adults With Knee Osteoarthritis.

Authors:  Hyochol Ahn; Jun-Ho La; Jin M Chung; Hongyu Miao; Chengxue Zhong; Miyong Kim; Kyungeh An; Debra Lyon; Eunyoung Choi; Roger B Fillingim
Journal:  Biol Res Nurs       Date:  2019-05-30       Impact factor: 2.522

Review 7.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

8.  Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.

Authors:  Cecilea C Clayton; Michael R Bruchas; Michael L Lee; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2009-12-03       Impact factor: 4.436

9.  The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia.

Authors:  Hui Fan; Nian Gong; Teng-Fei Li; Ai-Niu Ma; Xiao-Yan Wu; Ming-Wei Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

10.  Do Resting Plasma β-Endorphin Levels Predict Responses to Opioid Analgesics?

Authors:  Stephen Bruehl; John W Burns; Rajnish Gupta; Asokumar Buvanendran; Melissa Chont; Daria Orlowska; Erik Schuster; Christopher R France
Journal:  Clin J Pain       Date:  2017-01       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.